You just read:

MaxCyte, NIH NIAID Study Published in Science Translational Medicine Demonstrates CRISPR-Cas9 Repair of X-linked Chronic Granulomatous Disease (CGD) Gene

News provided by

MaxCyte, Inc.

12 Jan, 2017, 09:00 ET